The Health Communications Core (HCC) provides interdisciplinary support to University of Michigan Comprehensive Cancer Center (UMCCC) Investigators In the design, development, and delivery of research interventions requiring targeted and tailored communications across the continuum of cancer care. The Core provides scientific expertise regarding tailored health communication, individual counseling, intervention design, study protocols, and the development of evaluation instruments;behavioral science expertise and tailored content development;technical engineering and programming, including web, print, mobile device, social media;creative media design and development. Including graphic design, illustration, animation, photography, audio engineering, video production, music composition, and advanced web programming;activities in support of data collection, management, and reporting;assistance in the planning of analyses, interpretation of results, and presentation and publication of research findings;and all aspects of project management. Rapid change in the national and global Information technology landscape has created the unprecedented opportunity and critical need for interactive health communications strategies that can be tailored to the specific health needs of the individual and of special populations. In developing a broad spectrum of interactive health communications interventions for investigators conducting cancer prevention, cancer control, and clinical and translational research, the Health Communications Core (HCC) supports multiple facets of the overall research mission of the University of Michigan Comprehensive Cancer Center (UMCCC). The primary aim of the HCC is to support UMCCC Investigators in the design, development, and delivery of state-of-the-science health communications research programs. Achieving this aim depends on the HCC's organization, staff, and Interactions with UMCCC Investigators. Organizing the multidisciplinary staff and technical resources into a unified, cooperative Core allows the HCC to develop and Implement Interventions In a more effective, efficient manner. This core institutionalizes a long-standing commitment of the University of Michigan's Center for Health Communications Research (CHCR) to provide a robust communications resource for all Cancer Center investigators. The HCC plans significant Interactions with other UMCCC Cores, particularly the proposed Patient and Population Sciences Core, the Cancer Informatics Core, and the Biostatistics Core.
The primary aim of the Core is to support UMCCC Investigators in the design, development, and delivery of state-of-the-science health communications programs. Rapid change In the national and global information technology landscape has created the unprecedented opportunity and critical need for interactive health communications Strategies that can be tailored to the specific health needs of the Individual and of special populations.
|Skolarus, Ted A; Metreger, Tabitha; Hwang, Soohyun et al. (2017) Optimizing veteran-centered prostate cancer survivorship care: study protocol for a randomized controlled trial. Trials 18:181|
|Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668|
|Pinskey, Justine M; Franks, Nicole E; McMellen, Alexandra N et al. (2017) Neuropilin-1 promotes Hedgehog signaling through a novel cytoplasmic motif. J Biol Chem 292:15192-15204|
|Maj, Tomasz; Wang, Wei; Crespo, Joel et al. (2017) Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor. Nat Immunol 18:1332-1341|
|Zhang, Jie; Feng, Shumei; Su, Wenmei et al. (2017) Overexpression of FAM83H-AS1 indicates poor patient survival and knockdown impairs cell proliferation and invasion via MET/EGFR signaling in lung cancer. Sci Rep 7:42819|
|Mann, J E; Hoesli, R; Michmerhuizen, N L et al. (2017) Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC. J Cancer 8:332-344|
|Birkeland, Andrew C; Foltin, Susan K; Michmerhuizen, Nicole L et al. (2017) Correlation of Crtc1/3-Maml2 fusion status, grade and survival in mucoepidermoid carcinoma. Oral Oncol 68:5-8|
|Walline, Heather M; Goudsmit, Christine M; McHugh, Jonathan B et al. (2017) Integration of high-risk human papillomavirus into cellular cancer-related genes in head and neck cancer cell lines. Head Neck 39:840-852|
|Walline, Heather M; Carey, Thomas E; Goudsmit, Christine M et al. (2017) High-Risk HPV, Biomarkers, and Outcome in Matched Cohorts of Head and Neck Cancer Patients Positive and Negative for HIV. Mol Cancer Res 15:179-188|
|Chen, Yan; Zhou, Quan; Li, Xue et al. (2017) Ultrasmall Paramagnetic Iron Oxide Nanoprobe Targeting Epidermal Growth Factor Receptor for In Vivo Magnetic Resonance Imaging of Hepatocellular Carcinoma. Bioconjug Chem 28:2794-2803|
Showing the most recent 10 out of 1355 publications